Coralie Lecomte
Overview
Explore the profile of Coralie Lecomte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okami S, Lecomte C, Raad H, Aguila M, Mohrova Z, Takeichi M, et al.
Sci Rep
. 2024 Oct;
14(1):24193.
PMID: 39406947
No abstract available.
2.
Okami S, Ohlmeier C, Takeichi M, Aguila M, Holl K, Michel A, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892932
Vericiguat was developed to treat patients with heart failure (HF). Currently, limited data are available to characterize vericiguat-treated patients in real-world clinical settings. This retrospective cohort study was done using...
3.
Okami S, Lecomte C, Raad H, Aguila M, Mohrova Z, Takeichi M, et al.
Sci Rep
. 2024 Apr;
14(1):9095.
PMID: 38643208
Currently, the utilization patterns of medications for heart failure (HF) after worsening HF events remain unelucidated in Japan. Here, we conducted a retrospective cohort study evaluating the changes in HF...
4.
Michel A, Lecomte C, Ohlmeier C, Raad H, Basedow F, Haeckl D, et al.
Am J Cardiovasc Drugs
. 2024 Apr;
24(3):409-418.
PMID: 38573461
Background: Data are limited regarding guideline-directed medical therapy (GDMT) treatment patterns in patients with worsening heart failure (HF). Methods: We used administrative claims databases in Germany and the USA to...
5.
Alloza C, Knox B, Raad H, Aguila M, Coakley C, Mohrova Z, et al.
Clin Pharmacol Ther
. 2023 Jul;
114(4):795-801.
PMID: 37441734
Regulators are faced with many challenges surrounding health data usage, including privacy, fragmentation, validity, and generalizability, especially in the European Union, for which synthetic data may provide innovative solutions. Synthetic...
6.
Ting A, Story T, Lecomte C, Estrin A, Syed S, Lee E
J Neurol Sci
. 2023 Jan;
445:120531.
PMID: 36634582
Despite current treatments, patients with myasthenia gravis (MG) experience unpredictable and inadequately controlled symptoms, lending to variability in the clinical and economic burden of disease. However, limited data are available...
7.
Bricout H, Torcel-Pagnon L, Lecomte C, Almas M, Matthews I, Lu X, et al.
PLoS One
. 2019 Aug;
14(8):e0220230.
PMID: 31369608
Background: The United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013-2014). That year, vaccination coverage ranged from 50 to 64% across the...
8.
Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, et al.
Vaccine
. 2012 Dec;
31(8):1246-54.
PMID: 23246544
Background: In August 2010 reports of a possible association between exposure to AS03 adjuvanted pandemic A(H1N1)pdm09 vaccine and occurrence of narcolepsy in children and adolescents emerged in Sweden and Finland....
9.
Smith D, Terrebonne E, Rouyer M, Blanc J, Breilh D, Pedeboscq S, et al.
Fundam Clin Pharmacol
. 2011 Jul;
27(1):113-9.
PMID: 21793898
Introduction of new agents for the treatment for colorectal cancer (CRC) has been accompanied by the publication of guidelines. The COLCHIC cohort was set up to evaluate CRC treatment practices...